NEUMORA THERAPEUTICS, INC. (NMRA) Operating income 2022–2025
NEUMORA THERAPEUTICS, INC. (NMRA) annual operating income history from SEC filings — each fiscal year as reported.
-$241.2MFY2025 · since FY2022: -$135.9M → -$241.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.2M | +8.5% |
| FY2024 | -$263.5M | -4.5% |
| FY2023 | -$252.1M | -85.5% |
| FY2022 | -$135.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMRA financial trends
NMRA RevenueNMRA Net incomeNMRA Net marginNMRA Gross profitNMRA Gross marginNMRA Operating marginNMRA Operating cash flowNMRA Free cash flowNMRA Capital expendituresNMRA Return on equityNMRA Stock buybacksNMRA Dividends paidNMRA Total assetsNMRA Total liabilitiesNMRA Shareholders’ equityNMRA overview →